Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)

Clinical trial NCT02606136 · TERMINATED

Trial details

NCT number: NCT02606136
Sponsor: Kyntra Bio
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2016-01-04
Primary completion: 2020-05-07
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.